FDA Expands Approval of Roflumilast Cream (Zoryve) to Younger Children with Plaque Psoriasis
As reported on Healio, the U.S. Food and Drug Administration has broadened the indication for roflumilast cream 0.3% (Zoryve, Arcutis), allowing its use in children with plaque psoriasis as young…